The changes in TT, PT, APTT and FIB level with time were not found to be significant in the ISO and SEVO groups. The difference between the Z
2 and Z
3 measurements of TT was statistically significant (
P<0.05); however, TT levels in both groups were within the physiological limits (Table 1).
During anesthesia, heart and respiratory rates of all animals in the ISO and SEVO groups remained within normal physiological limits.
When TT values are found to be high, hereditary causes such as afibrinogenemia, hypofibrinogenemia and dysfibrinogenemia, as well as acquired conditions such as heparin therapy or contamination and disseminated intravascular coagulation should be investigated
Seligsohn and Coller (2001). It is equivalent to APTT but less reliable. It measures the conversion of fibrinogen into fibrin
Aktas et al., (2005). Van
Lue et al., (2007) reported that the TT level in venous blood samples was 11.34 ± 1.49 g/L.
In this study, the decreases in TT values in Z2 and Z3 in the ISO group were found to be statistically significant compared with the TT values in Z0 in the ISO and SEVO groups (
P<0.05).
Regarding the TT values in both groups, the differences between intraoperative and postoperative values were statistically significant. However, these changes were within the reference values, supporting the findings of
Van Lue et al., (2007).
Munro et al., (1997) conducted a study on humans and reported that the thrombocyte counts were less than 1.1%, PT increased 0.4%–4.8% and APTT increased 0%–15.6% in preoperative tests conducted on asymptomatic individuals.
PT is used for a mix of initial tissue factors and phospholipids. It is measured as a parameter to evaluate the extrinsic coagulation pathways Brainard (2015). In this test, the time from the extrinsic pathway to fibrin clot formation is measured by adding plasma calcium and prothrom boplastin (tissue factor). If the levels of factor VII found in the extrinsic pathway, factors X and V found in the common pathway, prothrombin and fibrinogen are normal, PT is found to be normal. PT elongation is not observed until the aforementioned values drop below 10% of the normal. PT elongation is seen only in inherited factor VII deficiency. It is also seen in liver diseases, vitamin K deficiency, and the use of inhibitors against factor VII
Roger and Bithell (1999).
Chohan et al., (2011) reported that the initial value of PT was 7.8 ± 0.8 (6.7–9.1) s. Van
Lue et al., (2007) applied general anesthesia using ISO following a minor surgery and propofol induction on dogs and determined the PT values of blood samples as 7.23 ± 0.70 s.
The PT values in the ISO and SEVO groups were compared in this study, and no statistically significant differences were found (
P> 0.05).
In the present study, it was found that the initial PT values did not significantly change compared with the intraoperative and postoperative values, in line with the literature.
APTT is used to measure intrinsic factors (factors XII, XI, IX and VIII) and the common coagulation pathway
Chohan et al., (2011). During APTT measurement, the time from the intrinsic pathway to the fibrin clot formation is measured by adding an activator such as phospholipids, calcium and ellagic acid or kaolin to the plasma. APTT elongation is not seen until the level of clotting factors drops as low as 15%–30% below normal. APTT prolongation is seen in the absence of inherited factors VIII, IX, XI, or XII. APTT is prolonged in the presence of specific or nonspecific inhibitors against the aforementioned factors, following heparin therapy and in the presence of antiphospholipid antibodies. Rare hereditary causes such as the deficiency of factor XII, prekallikrein and HMWK should be considered in patients with a history of prolonged APTT without bleeding. The prolonged TT in patients with high APTT values supports the presence of heparin. Factor XIII may be lacking in patients with normal PT and APTT values and a history of serious bleeding
Turgut et al., (2000) Sencan (2004).
Chohan et al., (2011) found the APTT level in healthy dogs to be 11.2 ± 0.6 s. Van
Lue et al., (2007) reported the APTT level as 13.85 ± 5.12 s.
The differences between the APTT values in the ISO and SEVO groups were not statistically significant (
P > 0.05).
Fibrinogen forms in the parenchyma cells of the liver. It is a soluble plasma protein. It is transformed into a nonsoluble fibrin. It is not found in the serum. Its molecular weight is 380,000
D Yýlmaz, (2000). TT depends on the level of blood fibrinogen and is determined by measuring fibrin formation in the common pathway
Brainard (2015). Van
Lue et al., (2007) found the fibrinogen levels in venous blood samples as 2.23 ± 0.94 g/L. They also reported decreased arterial fibrinogen levels and prolonged TT.
In this study, no statistical differences were found between the fibrinogen values in the ISO and SEVO groups (
P > 0.05).
The results in both groups were within normal limits in the present study. The combination of two anesthetics did not have an adverse effect on the plasminogen level and these data were in parallel with the literature. The TT values were also within normal limits. In this respect, it differs from the mentioned report. This suggests that the use of acepromazine had an effect in premedication in the study.
Amarpal et al., (1999) demonstrated that ketamine given epidurally to dogs before fracture repair decreased post- operative pain for up to 15 days as compared to dogs receiving saline. Epidurally administered opioids have been shown to provide analgesia for both visceral and somatic pain that can persist in the dog for 10- 24 hours
Ram et al., (2014). In this study, no statistically significant differences were found between the two groups. However, the preoperative, intraoperative, and postoperative findings of this study were found to be higher compared with the aforementioned two studies. The data suggested that the midazolam–propofol–ISO and midazolam–propofol–SEVO anesthesia had no negative effects on the coagulation parameters.
Therefore, it was concluded that ISO and SEVO anesthesia applied during OHE in this study had no adverse effect on the coagulation parameters and hence they could be used safely in patients with coagulation disorders in clinical practice. Studies with more detailed parameters should be conducted to validate the findings of this study.